European Intravitreal Avastin® Trial 1

Update Il y a 4 ans
Reference: EUCTR2005-003132-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To investigate functional vision outcomes of intravitreal Bevacizumab (Avastin®), a recombinant humanized anti-VEGF monoclonal antibody, administered as multiple intraocular injections in patients with neovascular age-related macular degeneration compared to standard of care.


Inclusion criteria

  • Neovascular / exudative age-related macular degeneration

Links